Listed equity
Procter & Gamble Health
मैजेस्को · મૅજેસ્કો
₹229.35▲₹3.05(+1.34%)
EOD close · 3 Jul 2026
mid rallyneutral -4
Above 50- and 200-day MAs with +32.8% over 3 months — established uptrend.
52W low ₹151.1052W high ₹237.35
Now at 91% of its 52-week range
Long-term returns
1Y
+17.8%
3Y
+84.2%
5Y
+151.5%
10Y
-57.0%
Phase indicator
mid rally-3.4% from 52w high
Above 50- and 200-day MAs with +32.8% over 3 months — established uptrend.
1M
+27.8%
3M
+32.8%
1Y
+17.8%
Delivery conviction
neutralscore -4
Delivery vs 20-day avg0.66x
Lifetime story
Procter & Gamble Health is up 1779.9% from its lifetime low of ₹12.20 on 23 Dec 2020. ₹10,000 invested then would be worth ₹1,87,992 today (70.1% CAGR over 5.5 years). Lifetime high of ₹1019.00 was set on 15 Dec 2020 (currently -77.5% below).
Fundamentals
Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.
150% premium to industry(Industry P/E 39.2)
| Standalone | Consolidated | |
|---|---|---|
| P/E (TTM)subs material | 98.15 | 922.60 |
| P/B | 2.94 | 3.50 |
| Price / Cash flowsubs material | 78.19 | 16.76 |
| Dividend yield | — | — |
| Book value / share | 78.56 ₹ | 65.94 ₹ |
| EPS (TTM)subs material | 2.35 ₹ | 0.25 ₹ |
Market cap
₹1.8K Cr
52W high
₹237.35
3 Jul 2026
52W low
₹151.10
30 Mar 2026
Returns ladder
1W
+7.5%
1M
+27.8%
3M
+32.8%
6M
+23.3%
YTD
+22.7%
1Y
+17.8%
3Y
+84.2%
5Y
+151.5%
10Y
-57.0%
Since listing
-29.1%